203 related articles for article (PubMed ID: 29246969)
1. Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.
Trochet D; Prudhon B; Beuvin M; Peccate C; Lorain S; Julien L; Benkhelifa-Ziyyat S; Rabai A; Mamchaoui K; Ferry A; Laporte J; Guicheney P; Vassilopoulos S; Bitoun M
EMBO Mol Med; 2018 Feb; 10(2):239-253. PubMed ID: 29246969
[TBL] [Abstract][Full Text] [Related]
2. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
3. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
4. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
5. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease.
Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811
[TBL] [Abstract][Full Text] [Related]
6. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
[TBL] [Abstract][Full Text] [Related]
7. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
8. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
9. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
Liewluck T; Lovell TL; Bite AV; Engel AG
Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
[TBL] [Abstract][Full Text] [Related]
10. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
[TBL] [Abstract][Full Text] [Related]
11. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy.
F Almeida C; Bitoun M; Vainzof M
FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
13. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
14. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
15. Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy.
Trochet D; Prudhon B; Mekzine L; Lemaitre M; Beuvin M; Julien L; Benkhelifa-Ziyyat S; Bui MT; Romero N; Bitoun M
Mol Ther Nucleic Acids; 2022 Mar; 27():1179-1190. PubMed ID: 35282416
[TBL] [Abstract][Full Text] [Related]
16. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
18. Allele-Specific CRISPR/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes.
Rabai A; Reisser L; Reina-San-Martin B; Mamchaoui K; Cowling BS; Nicot AS; Laporte J
Mol Ther Nucleic Acids; 2019 Jun; 16():246-256. PubMed ID: 30925452
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
[TBL] [Abstract][Full Text] [Related]
20. Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations.
Dudhal S; Mekzine L; Prudhon B; Soocheta K; Cadot B; Mamchaoui K; Trochet D; Bitoun M
Mol Ther Nucleic Acids; 2022 Sep; 29():733-748. PubMed ID: 36090755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
